Literature DB >> 23334589

Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis.

Aaron E Hoffman1, Ran Liu, Alan Fu, Tongzhang Zheng, Frank Slack, Yong Zhu.   

Abstract

BACKGROUND: miRNAs have been implicated in numerous tumorigenic pathways, and previous studies have associated miR-202 dysregulation with various cancer types, including follicular lymphoma.
METHODS: The miR-202 targetome was identified by ribonucleoprotein immunoprecipitation-microarray (RIP-Chip), and functional interactions among identified targets were investigated using the Ingenuity Pathway Analysis tool. We also conducted a population-based genetic association study of a polymorphism within the miR-202 stem-loop sequence and risk of non-Hodgkin lymphoma. In vitro gain-of-function experiments were further conducted to elucidate the functional significance of the variant.
RESULTS: A total of 141 potential members of the miR-202 targetome were identified by a transcriptome-wide RIP-Chip assay. Functional interactions among identified targets suggested that miR-202-regulated genes are involved in biologic pathways relevant for hematologic function and cancer. Consistent with this, a genetic association analysis using human blood samples revealed a significant association between a germline mutation (rs12355840) in the miR-202 precursor sequence and follicular lymphoma risk. An in vitro functional assay further showed that the variant allele resulted in diminished miR-202 levels, possibly by altering precursor-processing efficiency.
CONCLUSIONS: Taken together, our findings suggest that miR-202 is involved in follicular lymphomagenesis. IMPACT: These findings implicate miR-202 as a potential tumor suppressor in follicular lymphoma and warrant the investigation of miR-202 as a novel biomarker of follicular lymphoma risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334589      PMCID: PMC3905613          DOI: 10.1158/1055-9965.EPI-12-1131-T

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

Review 1.  Developing therapeutic microRNAs for cancer.

Authors:  A G Bader; D Brown; J Stoudemire; P Lammers
Journal:  Gene Ther       Date:  2011-06-02       Impact factor: 5.250

2.  Dicer recognizes the 5' end of RNA for efficient and accurate processing.

Authors:  Jong-Eun Park; Inha Heo; Yuan Tian; Dhirendra K Simanshu; Hyeshik Chang; David Jee; Dinshaw J Patel; V Narry Kim
Journal:  Nature       Date:  2011-07-13       Impact factor: 49.962

3.  Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus.

Authors:  YanLiang Zhang; Yong Dai; YuanShuai Huang; Liguo Ma; Yibing Yin; Min Tang; Chengxiao Hu
Journal:  J Obstet Gynaecol Res       Date:  2009-10       Impact factor: 1.730

4.  MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.

Authors:  Maria Pia Arrate; Tiffaney Vincent; Jessica Odvody; Rekha Kar; Stephen N Jones; Christine M Eischen
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

5.  OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

Authors:  Pedro P Medina; Mona Nolde; Frank J Slack
Journal:  Nature       Date:  2010-08-08       Impact factor: 49.962

6.  DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.

Authors:  Ingrid Slade; Chiara Bacchelli; Helen Davies; Anne Murray; Fatemeh Abbaszadeh; Sandra Hanks; Rita Barfoot; Amos Burke; Julia Chisholm; Martin Hewitt; Helen Jenkinson; Derek King; Bruce Morland; Barry Pizer; Katrina Prescott; Anand Saggar; Lucy Side; Heidi Traunecker; Sucheta Vaidya; Paul Ward; P Andrew Futreal; Gordan Vujanic; Andrew G Nicholson; Neil Sebire; Clare Turnbull; John R Priest; Kathryn Pritchard-Jones; Richard Houlston; Charles Stiller; Michael R Stratton; Jenny Douglas; Nazneen Rahman
Journal:  J Med Genet       Date:  2011-01-25       Impact factor: 6.318

7.  Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

Authors:  Lucia Conde; Eran Halperin; Nicholas K Akers; Kevin M Brown; Karin E Smedby; Nathaniel Rothman; Alexandra Nieters; Susan L Slager; Angela Brooks-Wilson; Luz Agana; Jacques Riby; Jianjun Liu; Hans-Olov Adami; Hatef Darabi; Henrik Hjalgrim; Hui-Qi Low; Keith Humphreys; Mads Melbye; Ellen T Chang; Bengt Glimelius; Wendy Cozen; Scott Davis; Patricia Hartge; Lindsay M Morton; Maryjean Schenk; Sophia S Wang; Bruce Armstrong; Anne Kricker; Sam Milliken; Mark P Purdue; Claire M Vajdic; Peter Boyle; Qing Lan; Shelia H Zahm; Yawei Zhang; Tongzhang Zheng; Nikolaus Becker; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Katja Butterbach; Pierluigi Cocco; Lenka Foretova; Marc Maynadié; Silvia de Sanjosé; Anthony Staines; John J Spinelli; Sara J Achenbach; Timothy G Call; Nicola J Camp; Martha Glenn; Neil E Caporaso; James R Cerhan; Julie M Cunningham; Lynn R Goldin; Curtis A Hanson; Neil E Kay; Mark C Lanasa; Jose F Leis; Gerald E Marti; Kari G Rabe; Laura Z Rassenti; Logan G Spector; Sara S Strom; Celine M Vachon; J Brice Weinberg; Elizabeth A Holly; Stephen Chanock; Martyn T Smith; Paige M Bracci; Christine F Skibola
Journal:  Nat Genet       Date:  2010-07-18       Impact factor: 38.330

8.  Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.

Authors:  J Buechner; E Tømte; B H Haug; J R Henriksen; C Løkke; T Flægstad; C Einvik
Journal:  Br J Cancer       Date:  2011-06-07       Impact factor: 7.640

9.  Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

Authors:  Ryan D Morin; Maria Mendez-Lago; Andrew J Mungall; Rodrigo Goya; Karen L Mungall; Richard D Corbett; Nathalie A Johnson; Tesa M Severson; Readman Chiu; Matthew Field; Shaun Jackman; Martin Krzywinski; David W Scott; Diane L Trinh; Jessica Tamura-Wells; Sa Li; Marlo R Firme; Sanja Rogic; Malachi Griffith; Susanna Chan; Oleksandr Yakovenko; Irmtraud M Meyer; Eric Y Zhao; Duane Smailus; Michelle Moksa; Suganthi Chittaranjan; Lisa Rimsza; Angela Brooks-Wilson; John J Spinelli; Susana Ben-Neriah; Barbara Meissner; Bruce Woolcock; Merrill Boyle; Helen McDonald; Angela Tam; Yongjun Zhao; Allen Delaney; Thomas Zeng; Kane Tse; Yaron Butterfield; Inanç Birol; Rob Holt; Jacqueline Schein; Douglas E Horsman; Richard Moore; Steven J M Jones; Joseph M Connors; Martin Hirst; Randy D Gascoyne; Marco A Marra
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

10.  Regression of murine lung tumors by the let-7 microRNA.

Authors:  P Trang; P P Medina; J F Wiggins; L Ruffino; K Kelnar; M Omotola; R Homer; D Brown; A G Bader; J B Weidhaas; F J Slack
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

View more
  20 in total

1.  miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2.

Authors:  Zhengwen Sun; Tongqing Zhang; Huanyu Hong; Qingxia Liu; Haiguang Zhang
Journal:  Mol Cell Biochem       Date:  2014-08-26       Impact factor: 3.396

2.  From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants.

Authors:  Lois M Dodson; Alessandro Baldan; Mikael Nissbeck; Sethu M R Gunja; Penelope E Bonnen; Geraldine Aubert; Sherri Birchansky; Anders Virtanen; Alison A Bertuch
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

3.  Altered expression of miR-202 in cerebellum of multiple-system atrophy.

Authors:  Soon-Tae Lee; Kon Chu; Keun-Hwa Jung; Jae-Jun Ban; Woo-Seok Im; Hee-Yeon Jo; Ji-Hyun Park; Ji-Yeon Lim; Jung-Won Shin; Jangsup Moon; Sang Kun Lee; Manho Kim; Jae-Kyu Roh
Journal:  Mol Neurobiol       Date:  2014-07-01       Impact factor: 5.590

Review 4.  The peopling of the African continent and the diaspora into the new world.

Authors:  Michael C Campbell; Jibril B Hirbo; Jeffrey P Townsend; Sarah A Tishkoff
Journal:  Curr Opin Genet Dev       Date:  2014-12       Impact factor: 5.578

5.  miR-202-3p negatively regulates MMP-1 to inhibit the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Yong Li; Huiqin Huang; Xiangli Ye; Zhenghui Huang; Xiangqi Chen; Feng Wu; Tingyan Lin
Journal:  Cell Cycle       Date:  2021-01-25       Impact factor: 4.534

6.  Targetome profiling and functional genetics implicate miR-618 in lymphomagenesis.

Authors:  Alan Fu; Aaron E Hoffman; Ran Liu; Daniel I Jacobs; Tongzhang Zheng; Yong Zhu
Journal:  Epigenetics       Date:  2014-02-06       Impact factor: 4.861

7.  TNF-α and IGF1 modify the microRNA signature in skeletal muscle cell differentiation.

Authors:  Swanhild U Meyer; Christian Thirion; Anna Polesskaya; Stefan Bauersachs; Sebastian Kaiser; Sabine Krause; Michael W Pfaffl
Journal:  Cell Commun Signal       Date:  2015-01-29       Impact factor: 5.712

8.  MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families.

Authors:  Daniel Fischer; Tiina Wahlfors; Henna Mattila; Hannu Oja; Teuvo L J Tammela; Johanna Schleutker
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

9.  CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.

Authors:  Mosavar Farahani; Carlos Rubbi; Luning Liu; Joseph R Slupsky; Nagesh Kalakonda
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

10.  Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer.

Authors:  Yu Zhao; Chenglong Li; Ming Wang; Liping Su; Ying Qu; Jianfang Li; Beiqin Yu; Min Yan; Yingyan Yu; Bingya Liu; Zhenggang Zhu
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.